Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer

Phase 1

Completed

Conditions: Esophageal Cancer

Interventions: Drug: docetaxel
Drug: cisplatin
Radiation: radiation therapy
Drug: irinotecan hydrochloride

First Posted Date: 2008-01-28

Last Posted Date: 2013-03-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 27

Registration Number: NCT00601692

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.

Completed

Conditions: Basal Cell Carcinoma
Melanoma
Squamous Cell Carcinoma
Non-Malignant Skin Disorders

Interventions: Procedure: confocal microscopy in vivo

First Posted Date: 2008-01-25

Last Posted Date: 2018-02-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 116

Registration Number: NCT00601185

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center Hauppauge, Hauppauge, New York, United States
🇺🇸
Memorial Sloan Kettering West Harrison, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 1 locations

Assess the Feasibility of Cone Beam CT to Localize Liver Metastases Immediately Prior to Radiotherapy

Not Applicable

Completed

Conditions: Localize Liver Metastases

Interventions: Radiation: cone beam imaging

First Posted Date: 2008-01-25

Last Posted Date: 2015-05-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 6

Registration Number: NCT00600613

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Language Function in Patients With Brain Tumors

Completed

Conditions: Brain Cancer
CNS Cancer

Interventions: Other: fMRI Scan, pre- and post language evaluation

First Posted Date: 2008-01-24

Last Posted Date: 2009-07-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 7

Registration Number: NCT00599703

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Functional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Construction Approaches

Completed

Conditions: Larynx Cancer

Interventions: Behavioral: questionnaires and standardized, digital voice recording

First Posted Date: 2008-01-24

Last Posted Date: 2010-10-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 5

Registration Number: NCT00600223

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Quality of Life Among Long-Term Survivors of Resected Gastric Cancer

Completed

Conditions: Gastric Cancer

Interventions: Behavioral: EORTC QLQ-C30, QLQ-STO22, and MSK-10

First Posted Date: 2008-01-22

Last Posted Date: 2009-07-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 212

Registration Number: NCT00598546

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors

Not Applicable

Completed

Conditions: Sarcoma
Bone Tumor

Interventions: Other: DCE-MRI

First Posted Date: 2008-01-22

Last Posted Date: 2014-04-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 61

Registration Number: NCT00598741

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Quality of Life Among Survivors of Hodgkin Lymphoma

Completed

Conditions: Hodgkin's Disease

Interventions: Behavioral: Quality of Life Questionaires

First Posted Date: 2008-01-22

Last Posted Date: 2016-04-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 255

Registration Number: NCT00598728

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous Melanoma

Not Applicable

Completed

Conditions: Melanoma

Interventions: Biological: KLH conjugates with GD2L and GD3L

First Posted Date: 2008-01-18

Last Posted Date: 2016-09-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 34

Registration Number: NCT00597272

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Biomarkers of Molecular Risk in Smokers

Completed

Conditions: Smoking Cessation

Interventions: Behavioral: Vignette, questionnaires and Saliva Samples
Behavioral: Urine Collection, Smoking cessation treatment

First Posted Date: 2008-01-18

Last Posted Date: 2015-05-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 45

Registration Number: NCT00598143

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy